Abbreviations
KU Leuven is one of Europe’s oldest universities, which consistently ranks amongst the world’s best universities and is widely regarded as one of the most innovative research institutions.
The KU Leuven Institute for Single Cell Omics (LISCO) nucleates interdisciplinary expertise in single-cell and spatial multi-omics to investigate normal development, aging and disease processes in humans and other organisms, down to the biology of unicellular life forms. LISCO aims to develop innovative single-cell analysis technologies and high-throughput platforms to enable breakthrough biomedical and biological science that transcends an individual research lab, to pioneer and set standards in disruptive single-cell technologies and research, and to translate technologies and biomedical discoveries to the clinic. It unites researchers from over 55 groups from KUL, UZ Leuven and VIB-KU Leuven, creating a framework for academic and industrial collaboration, service provision, and training of the next-generation researchers.
The Laboratory of Cell Stress & Immunity (CSI) is embedded within the Department of Cellular & Molecular Medicine (CMM), in KU Leuven (Belgium). The CSI laboratory is headed by Prof. Abhishek D. Garg and focuses on the following research themes: cancer immunology & immunotherapy, immunology of cellular stress & immunity cycle, computational immunology and multi-omics, single cell and spatial mapping in immuno-oncology. Ultimately, the CSI lab aims to specialise in reverse translational approaches to hasten progress in immuno-oncology and help improve the therapeutic outlook for cancer patients, in close collaboration with leading researchers, immunologists, and oncologists, in Belgium and abroad.
UZL is one of the participating organisations on behalf of KUL. UZL is the largest Belgian University Hospital and has a comprehensive multidisciplinary neuro-oncology team and works together with the Leuven Cancer Institute and Brain Tumor Focus Group and the Leuven Brain Institute.
What is KUL-LISCO’s main role?
Which work packages is KUL-LISCO involved in?
KUL-LISCO leads work packages 2 and 3 and contributes to work packages 1, 7 and 8.
See our dedicated page for more details on the GLIOMATCH work plan.
What is KUL-CMM’s main role?
Which work packages is KUL-CMM involved in?
KUL-CMM leads work package 1 and contributes to work packages 3, 4, 7 and 8.
See our dedicated page for more details on the GLIOMATCH work plan.
What is KUL-UZL’s main role?
Which work packages is KUL-UZL involved in?
KUL-UZL contributes to work packages 2, 5, 7 and 8.
See our dedicated page for more details on the GLIOMATCH work plan.
Who represents KUL-LISCO?
Who represents KUL-CMM?
Who represents KUL-UZL?
